Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

Journal of the National Cancer Institute

Volumn 94, Issue 1, 2002, Pages 26-31

  Esteller, Manel ^a,b   Gaidano, Gianluca ^c   Goodman, Steven N ^a   Zagonel, Vittorina ^d   Capello, Daniela ^c   Botto, Barbara ^e   Rossi, Davide ^c   Gloghini, Annunziata ^d   Vitolo, Umberto ^e   Carbone, Antonino ^d   Baylin, Stephen B ^a   Herman, James G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Hospital Infantil Universitario Niño Jesús   (Spain)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DNA; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; MELPHALAN; METHOTREXATE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PREDNISONE; VINBLASTINE; VINCRISTINE;

AGE; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DNA REPAIR; DRUG RESPONSE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; KAPLAN MEIER METHOD; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; NONBIOLOGICAL MODEL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN METHYLATION; RANK SUM TEST; RETROSPECTIVE STUDY; STUDENT T TEST;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DNA METHYLATION; DNA REPAIR; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037005988     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. Clinical manifestations, staging, and treatment of non-Hodgkin lymphoma
3. Molecular biology of lymphomas
4. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
5. DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal
6. 6-alkylguanine-DNA alkyltransferase
7. 6-methylguanine-DNA methyltransferase gene
8. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene
9. 6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing
10. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis
11. A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers
12. 6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain
13. 6-methylguanine-DNA methyltransferase activity in adult gliomas: Relation to patient and tumor characteristics
14. Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine
15. 6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bischloroethylnitrosourea: A Southwest Oncology Group study
16. 6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: Frequency and time to tumor progression after alkylating agent-based chemotherapy
17. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
18. Report of the Committee on Hodgkin's Disease Staging Classification
19. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma
20. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
21. 6-alkylguanine-DNA-alkyltransferase using newly developed monoclonal antibodies
22. 6-benzylguanine plus 1,3-bis(2-chloroethyl-1-nitrosourea
23. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G : C to A : T transition mutations in p53 in human colorectal tumorigenesis
24. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
25. 6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts
26. 6-alkylguanine-DNA alkyltransferase
27. 6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity
28. Mechanisms of resistance to the toxicity of cyclophosphamide
29. 6-benzylguanine and its role in chemotherapy
30. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents
31. 6-alkylguanine-DNA alkyltransferases
32. 6-benzylguanine followed by carmustine in patients with advanced cancer